Melinta Therapeutics, LLC
2 clinical trials · Sponsor
◉ Watch Melinta Therapeutics, LLC
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Safety of Intravenous Oritavancin for the Treatment of Children With Skin Infections (NCT05599295) | Melinta Therapeutics, LLC | 2023-06-15 |
| Open Label, Dose-finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Participants With Suspected or Confirmed Bacterial Infections (NCT02134301) | Melinta Therapeutics, LLC | 2014-05-01 |
Track Melinta Therapeutics, LLC automatically
Every clearance here is in the API, with alerts when new ones post.